Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Cellid is a biotech company specializing in the development of immunotherapeutic agents and vaccines. Leveraging its proprietary adenovirus vector platform technology, the company researches and develops oncology immunotherapies and prophylactic vaccines for infectious diseases. Its key pipeline includes BVAC-C, a therapeutic vaccine for cervical cancer, among others.
셀리드는 면역치료제 및 백신 개발 전문 바이오 기업입니다. 자체 개발한 아데노바이러스 벡터 플랫폼 기술을 기반으로 항암 면역치료제와 감염병 예방 백신을 연구 및 개발하고 있습니다. 주요 파이프라인으로는 자궁경부암 치료백신 BVAC-C 등이 있습니다.
